SB 1525Session 89R
Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.
Progress
- Introduced
- In committee
- Passed Senate
- Passed legislature Not yet
- Sent to governor Not yet
- Became law Not yet
What this bill would cost
-
Fiscal Note (Senate Committee Report)
No significant cost to the state is expected.
-
Fiscal Note (Introduced)
No significant cost to the state is expected.
Fiscal notes are prepared by the state’s budget staff and reflect the bill as written at the time.
Legislative history
-
House
Referred to Insurance
-
House
Read first time
-
House
Received from the Senate
-
Senate
Reported engrossed
-
Senate
Passed
-
Senate
Read 3rd time
-
Senate
Record vote
-
Senate
Three day rule suspended
-
Senate
Read 2nd time & passed to engrossment
-
Senate
Vote recorded in Journal
-
Senate
Rules suspended-Regular order of business
-
Senate
Co-author authorized
-
Senate
Placed on intent calendar
-
Senate
Committee report printed and distributed
-
Senate
Recommended for local & uncontested calendar
-
Senate
Reported favorably as substituted
-
Senate
Vote taken in committee
-
Senate
Considered in public hearing
-
Senate
Left pending in committee
-
Senate
Testimony taken in committee
-
Senate
Considered in public hearing
-
Senate
Scheduled for public hearing on . . .
-
Senate
Referred to Health & Human Services
-
Senate
Read first time
-
Senate
Filed
-
Senate
Received by the Secretary of the Senate